C84.11
Sézary disease, lymph nodes of head, face, and neck
Clinical Classification Guidelines
Medical Intelligence & Overview
Sézary disease is a rare and aggressive form of skin lymphoma classified under the ICD-10 code C84.11. It is a type of cutaneous T-cell lymphoma characterized by the presence of malignant T-cells in the skin, blood, and lymph nodes. Specifically, this variant involves lymph nodes located in the head, face, and neck regions. Often presenting with widespread skin redness, scaling, and an abundance of malignant cells in the bloodstream, Sézary disease can significantly impact a person’s quality of life and requires specialized medical attention for management.
Causes & Symptoms
Clinical Causes: The precise cause of Sézary disease remains unknown. It involves genetic mutations within T-lymphocytes that lead to malignant transformation. While most cases are sporadic, certain genetic predispositions or immune system factors may contribute. No clear environmental or lifestyle factors have been conclusively linked to its development. It is not contagious and cannot be transmitted from person to person.
Key Symptoms: Widespread redness and scaling of the skin (erythroderma) Intense itching or burning sensations Patchy or generalized rash covering large areas of the body Palpable enlarged lymph nodes in the head, face, and neck regions Presence of malignant T-cells (Sézary cells) in the blood, detectable through blood tests Nail deformities or thickening Sensation of skin thickening or induration Recurrent skin infections due to compromised skin barrier and immune function
Diagnostic & Treatment
Diagnosis Path: Detailed medical history and physical examination, emphasizing skin and lymph nodes Blood tests to identify Sézary cells and assess blood cell counts Skin biopsies to analyze skin tissue architecture and cellular characteristics Lymph node biopsies if enlarged nodes are present Imaging studies such as CT scans to evaluate lymph node involvement and rule out other conditions Molecular studies to detect genetic mutations associated with the disease
Treatment Protocols: Photopheresis (extracorporeal photoimmune therapy) to target malignant T-cells Systemic therapies such as skin-directed agents, chemotherapy, or targeted drugs Immunotherapy approaches to boost the immune response against malignant cells Topical corticosteroids and retinoids for skin lesions Radiation therapy in cases with localized lymphadenopathy Supportive care including skin moisturization and infection management Clinical trials exploring new therapies may be considered for eligible patients
Clinical Advice & FAQs
Billing Guidance
Is C84.11 a billable ICD-10 code?
Yes, C84.11 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C84.11?
Clinical documentation must specify the nature of Sézary disease, lymph nodes of head, face, and neck and any associated comorbidities for accurate reporting.
Cite this Clinical Reference